---
up: 
down: 
related: 
tags: []
aliases:
  - ANZCA.BT_GS 1.33
type: "[[LO.C.PEX.ANZCA]]"
order:
  - "[[Describe]]"
field:
  - "[[General Anaesthesia]]"
  - "[[Pharmacodynamics]]"
  - "[[Pharmacokinetics]]"
  - "[[Pharmacology]]"
dg-publish: true
title: ANZCA.4.3.8_BT_GS.1.33_Pharmacokinetic_Pharmacodynamic_Alterations_Anaesthetic_Agents
date created: Thursday, March 6th 2025, 12:41:28
date modified: Tuesday, March 25th 2025, 16:09:22
---

[[Describe]] [[alterations]] to the [[Pharmacokinetics]] and [[Pharmacodynamics]] of [[inhalational anaesthetic agents|inhalational]] and [[intravenous anaesthetic agents|intravenous anaesthetic agents]] for example:

* the [[elderly]]
* [[obesity]]
* [[cardiac disease|cardiac]], [[respiratory disease|respiratory]], [[renal disease|renal]], and [[hepatic disease]]
See also [[SS OB 1.1]], [[SS PA 1.52]] and [[SS PA 1.53]]
